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Matrix metalloproteinase 2 (MMP-2) is a proteolytic enzyme implicated in motility, 
differentiation and regeneration of skeletal muscle fibers through processing of extracellular 
substrates. Although MMP-2 has been found to be localized intracellularly in cardiomyocytes 
where the enzyme is thought to contribute to post-ischemic loss of contractility, little is 
known about intracellular MMP-2 activity in skeletal muscle fibers. In the present study we 
demonstrate intracellular MMP-2 in normal skeletal muscle by immunohistochemical 
staining. Immunogold electron microscopic analyses indicated that the enzyme was 
concentrated in Z-lines of the sarcomers, in the nuclear membrane and in mitochondria. By 
use of in situ zymography, we found that gelatinolytic activity in muscle fibers was co-
localized with immunofluorecent staining for MMP-2. Staining for MMP-9, the other member 
of the gelatinase group of the MMPs, was negative. The broad-spectrum metalloprotease 
inhibitor EDTA and the selective gelatinase inhibitor CTT2, but not the cysteine inhibitor 
E64, strongly reduced the gelatinolytic activity. The intracellular gelatinolytic activity was 
much more prominent in fast twitch type II fibers than in slow twitch type I fibers, and there 
was a decrease in intracellular gelatinolytic activity and MMP-2 expression in muscles from 
mice exposed to high intensity interval training. Together our results indicate that MMP-2 is 
part of the intracellular proteolytic network in normal skeletal muscle, especially in fast twitch 
type II fibers. Further, the results suggest that intracellular MMP-2 in skeletal muscle fibers is 






Matrix metalloproteinase 2 (MMP-2), also called gelatinase A, is produced by skeletal muscle 
fibers during homeostasis and is up-regulated by various physiological and pathological 
stimuli (Lewis et al., 2000; Carmeli et al., 2005; Carmeli et al., 2010; Dahiya et al., 2011; 
Alameddine, 2012). Through remodeling of the extracellular matrix (ECM) and by activation 
of signaling molecules the enzyme can affect motility, differentiation and regeneration of the 
myofibers (Chen and Li, 2009). The enzyme is also reported to be involved in the 
pathogenesis of muscular dystrophy and atrophy, though the precise mode of action is not 
well characterized (Fukushima et al., 2007; Kumar and Bhatnagar, 2010; Miyazaki et al., 
2011). Although MMP-2 has an N-terminal signal peptide that direct the enzyme for 
secretion, recent research suggests  that it is an inefficient signal causing retention of a 
substantial portion of the enzyme within cells (Ali et al., 2012). It is a major gelatinolytic 
enzyme, but can also degrade a number of other matrix and non-matrix substrates (Visse and 
Nagase, 2003; Rodriguez et al., 2010; Ali et al., 2011). Previously, extracellular functions 
have been the major focus in MMP-2 research, but recently intracellular variants along with 
several intracellular putative substrates of this MMP has been reported in some cell types 
(Cauwe and Opdenakker, 2010; Ali et al., 2011; Hadler-Olsen et al., 2011a). Many of the 
intracellular substrates have been detected by proteomic analyses, and the precise localization, 
activity and functions of intracellular MMP-2 is to a large extent unknown. In cardiomyocytes 
intracellular MMP-2 activity is believed to contribute to the reversible loss of contractile 
function after acute stress, such as ischemia-reperfusion.  In vitro and in vivo studies 
suggested that this was due to MMP-2 cleavage of troponin I, a central protein in the 
regulation of muscle contraction, as well as the cytoskeletal protein α-actinin (Bolli and 
Marban, 1999; Wang et al., 2002; Sung et al., 2007b). Other possible MMP-2 substrates in 
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cardiomyocytes include desmin, myosin light chain-1 and titin (Ali et al., 2011). Nuclear 
MMP-2 activity has been associated with apoptosis in several cell types such as in brain 
neuronal cells, pulmonary endothelial cells and cardiomyocytes (Kwan et al., 2004; Ruta et 
al., 2009; Yang et al., 2010; Hill et al., 2012). 
  Due to the similarity in structure and function of cardiac and skeletal muscles, we 
hypothesised that MMP-2 could be intracellularly localized and active also in skeletal muscle 
fibers. As MMP-2 is expressed in skeletal muscle during homeostasis (Lewis et al., 2000), we 
wanted to study putative intracellular MMP-2 localization and activity in normal, healthy 
muscle fibers. By immunohistochemistry and immunogold analyses we demonstrated MMP-2 
intracellularly in compartments not associated with the biosynthetic and secretory pathway in 
various groups of skeletal muscles in both mice and human. In situ zymography is a method 
to detect enzyme activity in a tissue section. A quenched, fluorescence-labeled substrate is put 
on top of a tissue section, and this substrate will be cleaved and fluorescence emitted in areas 
of the tissue where enzymes with specificity towards the chosen substrate are localized and 
active, in a time and dose-dependent manner. As sectioning will expose the interior of the vast 
majority of the cells in the tissue, no permeabilistaion is needed to study intracellular 
enzymes.  By in situ gelatin zymography combined with specific inhibitors and 
immunofluorescent MMP-2 staining we demonstrated that MMP-2 was active inside the 
muscle fibers. ATPase staining revealed that the activity was much more prominent in fast 
twitch type II fibers than in slow twitch type I fibers. Muscles from mice exposed to high 
intensity interval training showed decreased intracellular MMP-2 expression and gelatinolytic 
activity compared to their untrained littermates. Taken together our results demonstrate that 
MMP-2 is intracellularly localized and active inside skeletal muscle fibers during normal 
homeostasis. The expression and activity of the enzyme is most prominent in fast twitch type 
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II fibers and affected by physical activity, but the precise role of the enzyme and the 
underlying regulatory mechanisms can so far only be speculated.  
Materials and Methods 
Cell culturing 
The myoblast C2C12 cell line was purchased from Sigma–Aldricht (Sigma-Aldich, 
Steinheim, Germany). The cells were maintained in DMEM containing 4.5 g/L glucose 
(Sigma-Aldricht) and supplemented with 10 % FBS (V/V) (Sigma-Aldricht) in a humidified 
atmosphere of 5% CO2 at 37 ̊ C. 200 000 cells were seeded in 12-well plates, and allowed to 
attach for 6 hours before changing to a differentiation medium of DMEM containing 4.5 g/L 
glucose supplemented with 3 % horse serum (Sigma-Aldricht). The cells were allowed to 
differentiate into myocytes for six days before serum-free DMEM was added (1ml/well) after 
PBS rinsing. Conditioned, serum free medium was harvested after 48 hours, and added 
HEPES and CaCl2 to a final concentration of 0.1M and 0.01M respectively. Detached cells 
were removed by centrifugation at 1500 x g for 5 minutes at 4 ̊ C, and the supernatant was 
stored at -70 ̊ C until use.  After the medium was harvested, cells were washed three times 
with PBS before  cell lysates were prepared in 200 µl ice-cold lysisbuffer with proteinase 
inhibitor (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% Triton-X 100, 0.5% sodium 
deoxycholate, 0.1% SDS, 10 mM CaCl2- 2H2O, Sigmafast proteinase inhibitor cocktail, 
EDTA free). The cells were scraped, and the lysates collected, sonicated at 4 ̊ C in a 
BioRuptor Sonicator (Diagenode s.a, Liege, Belgum) and stored at -70 ̊ C. Protein content 
was determined using a Direct Detect Spectrometer (Millipore Corporation, Billerica, MA).  
Tissue samples 
Muscle tissue from the gastrocnemius muscle was harvested from 18 weeks old C57BL/6J 
male mice (Charles River Laboratories, Wilmington, USA). The mice were divided into two 
6 
 
groups each containing five mice; one which had a normal cage activity (control) and the 
other where the mice were subjected to five consecutive days of high intensity tread mill 
running once a day for  60 minutes as previously described (Hafstad et al., 2011).  The mice 
were sacrificed and the gastrocnemius muscle, which contains a mixture of slow twitch and 
fast twitch muscle fibers were isolated. For mice subjected to high intensity training, the 
muscles were isolated within minutes after the last round of training. From three untrained 
mice, samples of the gastrocnemius muscle were also put in Allprotect tissue reagent (Qiagen, 
Hilden, Germany) for subsequent homogenization and protein extraction. In order to study 
MMP-2 in muscles from different locations, tongues were harvested from the untrained mice. 
All mice were treated in accordance with the European Convention for the Protection of 
Vertebrate Animals for Experimental and Other Scientific Purposes’ guidelines on 
accommodation and care of animals, and the project was approved by the Animal Welfare 
Committee at the University of Tromsø. Samples for light microscopic analyses were fixed  in 
a Zn-based fixative (ZBF) (36.7 mM ZnCl2, 27.3 mM ZnAc2 x 2H2O and 0.63 mM CaAc2 in 
0.1 mol/l Tris pH 7.4), dehydrated and paraffin embedded. From three of the untrained mice, 
gastrocnemius muscles were also prepared for immunogold electron microscopic analyses by 
fixation in 4% formaldehyde in 200 mM Hepes, dehydration and epoxy resin embedding. To 
assess if MMP-2 staining was similar in muscles from mice and humans, five human ZBF-
fixed muscular tongue tissue samples were also analyzed.  In addition, three human biopsies 
from the vastus lateralis or biceps muscles were frozen in liquid nitrogen-cooled 
methylbutane and mounted with Tissue-Tek OCT (Sakura Finetek Europe, Alphen aan den 
Rijn, The Netherlands)   for ATPase staining and gelatin in situ zymography. The human 
biopsies were collected from the Department of Clinical pathology, University Hospital of 
North Norway, and all personal data were anonymous.  
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Immunohistochemistry, Immunofluorescence and Immunogold Analyses 
Immunohistochemistry was performed on 4µm thick sections of ZBF-fixed, paraffin 
embedded muscle tissue, from human and mouse tongues as well as the gastrocnemius muscle 
from mice, with two different primary rabbit antibodies against MMP-2 (NB200-193, Novus 
Biologicals, Littleton, CO, diluted 1:300 and ab37150, Abcam, Cambridge, MA giving 
similar results) or a rabbit anti MMP-9 antibody (Ab 38898 Abcam, Cambridge, MA, diluted 
1:800). Horseradish peroxidase (HRP)-labelled secondary antibody and diaminobenzidine 
substrate was used for visualization (EnVision
+
 system-HRP for rabbit primary antibodies, 
Dako, Glostrup, Denmark). Staining was performed as previously described (Hadler-Olsen et 
al., 2010; Solli et al., 2013) on five parallel samples from each location and species. 
Immunofluorescent staining was performed on the three parallels of mouse tongue and 
gastrocnemius samples with the primary rabbit MMP-2 antibody from Novus, and visualized 
with a Cy5 goat anti-rabbit secondary antibody (cat. # AP187S, Milipore Corporation, Cork, 
Ireland, diluted 1:200). Fluorescence was studied using a Leica TSC SP5 confocal laser 
microscope with Leica Application Suite Advanced Fluorescence software (Leica, Wetzlar, 
Germany). Sections in which the primary antibody was replaced by 5% normal goat serum 
were used as negative controls for both immunohistochemical and immunofluorescence 
analyses.  
Electron microscopic immunogold detection of MMP-2 was performed on three different 
gastrocnemius samples from mice with two different   MMP-2 primary rabbit antibodies 
(NB200-193, Novus Biologicals, diluted 1:200 and LS-B5182, LifeSpan Biosciences Inc., 
Seattle, WA, diluted 1:5, giving similar results). Prior to primary antibody incubation, 
unspecific staining was blocked with 0.8 % bovine serum albumin and 0.1 % gelatin 
from cold water fish skin (Sigma-Aldich, Steinheim, Germany).  Gold conjugated anti-
rabbit antibodies (10 nm) were used for detection (CMC, Utrecht, Netherlands).  
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Sections where the primary antibody was omitted were used as negative controls. The 
specificity of the antibodies has previously been validated by immunogold staining of 
cell lines expressing variable amounts of MMP-2 (Solli et al., 2013). Immunogold 
labelling was studied in a JEOL JEM-1010 transmission electron microscope (JEOL Ltd. 
Tokyo, Japan) equipped with a Morada digital camera (Olympus Corporation, Hamburg, 
Germany).   
ATPase activity was detected in three different unfixed human samples of the vastus 
lateralis or biceps muscle  at high pH (9.4) and low pH (4.5) according to standard 
procedures (Engel and Tice, 1966).   
In situ zymography 
Gelatinolytic activity was localized by in situ zymography on five parallel samples of  ZBF-
fixed gastrocnemius (from mouse) and tongue (from human and mouse) muscle samples, as 
well as on three unfixed human muscle samples from the biceps and vastus lateralis muscle as 
described earlier (Hadler-Olsen et al., 2010). To verify the contribution of metalloproteinases, 
20 mM EDTA was added to the substrate in control sections. As EDTA is a broad spectrum 
metalloproteinase inhibitor, the selective gelatinase (MMP-2 and MMP-9) inhibitor CTT2 
(Pirila et al., 2001; Heikkila et al., 2006) was also used in a 100 µM concentration to 
demonstrate the contribution of MMP-2 to the gelatinolytic activity. Cysteine proteases are 
known to be major intracellular enzymes; therefore 10 ng/ml of the cysteine protease inhibitor 
E-64 (Sigma-Aldirich, Steinheim, Germany) was added to other control sections to evaluate 
the contribution of such enzymes to the intracellular gelatinolytic activity. The inhibitors 
CTT2 and E64, applied in the in situ zymography, were tested for quenching, using 4 µg/ml 
FITC-labeled gelatin (Molecular Probes, Eugene, OR) in the presence or absence of 100 µM 
CTT2 or 10µM E64, in the in situ zymography assay buffer. The fluorescence was determined 
in a LS50 B Luminescence Spectrometer (Perkin Elmer, Waltham, MA), with excitation 
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wavelength of 490nm, emission wavelength of 520nm and slit width of 10 nm. Neither of the 
inhibitors could be regarded as quenchers as the fluorescence of the FITC-labeled gelatin was 
reduced by less than 0.5%.  
The level of auto-fluorescence in the tissue was assessed by incubating control sections 
at - 20˚C.  For some sections, in situ zymography was followed by immunofluorescent 
detection of MMP-2 as described in the previous section. Fluorescence was studied using 
a Leica TSC SP5 confocal laser microscope with Leica Application Suite Advanced 
Fluorescence software (Leica, Wetzlar, Germany).  
SDS-PAGE gelatin zymography and real-time reverse zymography 
To verify presence of MMP-2 in skeletal muscle by an antibody-independent technique, 
we also performed SDS-PAGE gelatin zymography on tissue extracts of gastrocnemius 
muscles from three parallel untrained mice as well as on cell lysates and serum-free 
conditioned medium of the murine myoblast cell line C2C12. The muscle tissue that was 
used for the extraction had been stored in Allprotect tissue reagent (Qiagen, Hilden, 
Germany) at -70 ̊C until use. Before protein extraction, the Allprotect tissue reagent was 
rinsed off by PBS, and tissue samples were homogenised as previously described 
(Hadler-Olsen et al., 2011b). The SDS-PAGE gelatin zymography was with gels 
containing 0.1% (w/v) gelatin and 4% and 7.5% (w/v) polyacrylamide in the stacking 
and separating gels, respectively performed (Hadler-Olsen et al., 2010). Gelatinolytic 
activity was evident as cleared regions. As molecular weight standard human pro-MMP-
9 dimer (225 kDa), pro- and processed MMP-9 monomer (92 kDa and 88kDa 
respectively) and pro- and processed human MMP-2 (72 kDa and 62 kDa respectively) 
was used. To evaluate the enzyme classes responsible for the observed gelatinolytic 
activity, two parallel gels were run. One was washed and incubated in buffers containing 
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10 mM EDTA, a metalloproteinase inhibitor, and the other in buffers without inhibitors 
(control). 
In addition, to assess for inhibitors of gelatinolytic enzymes in muscle, the same samples 
from muscle tissue and myoblast cells were subjected to real-time reverse SDS-PAGE 
zymography, as previously described (Mathisen et al., 2003). In brief, gels were 
prepared as for the SDS-PAGE gelatin zymography except that the separating gels 
contained 13% (w/v) polyacrylamide, 0.1 % 2-methoxy-2,4-diphenyl-3(2H)-furanone 
(MDPF)-labeled gelatin and conditioned medium from the THP-1 monocyte cell line 
which contains MMP-9 and TIMP-1. This medium was also used as a molecular weight 
standard. The gel was pre-run for 1 hour before the samples were loaded. During 
incubation 37 ̊C, the gels were observed every 30th minute under UV light until a clear 
contrast between the fluorescent inhibitor bands and the rest of the darkened gel had 
developed, and photographs were taken.  
Mass spectrometry 
To identify unknown gelatinolytic inhibitors detected by reverse SDS-PAGE substrate 
zymography, muscle tissue extract, C2C12 serum-free conditioned medium and cell 
lysate were subjected to non-reducing SDS-PAGE (NuPAGE Novex 4-12% Bis-Tris gels, 
Invitrogen, Carlsbad, CA). The gel was stained with Imperial Protein Stain (Thermo 
Scientific, Rockford, IL), and all defined protein bands with masses between 30 and 10 
kDa were cut out. Additionally, bands with masses between 80-60 kDa were cut out. The 
bands were subjected to mass spectrometric analyses as described in Supplementary 
file.  
Quantification and statistics  
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Volocity 3D Image Analysis Software (Perkin Elmer Inc., Waltham, MA) was used for 
quantification of the fluorescence intensity representing the in situ gelatinolytic activity 
or MMP-2 staining in muscle fibres from trained and normal control mice. Separating 
the fiber types was done manually in the Velocity Software using the freehand ROI tool. 
Areas of the sections where the tissue was disrupted in any way was excluded, 
otherwise all intact and focused cross sectioned fibers in the field were measured. The 
strongly fluorescent region in the periphery of the fibers, probably representing the 
sarcolemma, was included in the quantification. The quantification gives a value of 
average fluorescence per area in each fiber type. Based on the results from the ATPase 
and in situ gelatin zymography results described in the result section, fibers with little 
gelatinolytic activity were interpreted as type I fibers and fibers with strong 
gelatinolytic activity  as type II. The images used were of 20x magnification, and 3-4 
different images from one sample provided areas from the whole section to be analysed. 
To quantify gelatinolytic activity 235 type I and 220 type II fibers from 11 images of 3 
different samples were analysed from normal control mice, and 191 type I and 180 type 
II fibers from 9 images of 3 different samples were analysed from trained mice. To 
quantify MMP-2 immunofluorescent staining 97 type I and 193 type II fibers from 6 
images of 2 different samples were analysed from normal control mice, and 122 type I 
and 153 type II fibers from 6 images of 2 different samples were analysed from trained 
mice. 
 
Statistics were performed using SPSS software (Version 21, IBM, Armonk, New York). To 
analyse the normality of the populations of fiber type I and II in the different groups of 
mice, Shaphiro-Wilk test was used. Based on the results from this, Independent Samples 
t-test (for normally distributed populations) or Mann Whitney test (for not normally 
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distributed populations) were performed to determine if there were statistically 
significant differences in fluorescence intensity (in situ zymography and MMP-2 
immunofluorescent staining) between type I and type II fibers from normal and trained 
mice.  
Results 
Intracellular MMP-2 localization and activity in skeletal muscle fibers 
To assess intracellular MMP-2 localization in skeletal muscle tissue, tissue samples from 
different muscle groups in mice and humans were immunohistochemically stained for MMP-
2.  Staining pattern was similar in all muscles stained both in mice (Figure 1A and B, Figure 4 
C and D (immunofluorescence)) and humans (Supplementary file Figure S1 A and B). In 
longitudinally cut muscle fibers, a cross-striated staining pattern as well as staining of the 
nuclear membranes were seen in many myocytes (Figure 1A, S1A).The staining intensity 
varied somewhat between individual muscle fibers within a bundle. Cross sectioned muscle 
fibers also showed variable staining intensity of adjacent muscle fibers (Figure 1B, S1B). A 
slightly stronger staining was observed in the periphery of many myofibers which may 
correspond to the endomysium, the sarcolemma and/or mitochondria which are often found in 
large numbers in the periphery of muscle fibers (Figure 1B).   Negative control sections did 
not reveal any staining (Supplementary file Figure S1C). MMP-9/gelatinase B, the other 
member of the MMP gelatinase group, was not detected in any of the skeletal muscle fibers 
(Supplementary file, Figure S1D (mouse) and S1E (Human)). 
To further determine the intracellular localization of MMP-2 in the skeletal myofibers, 
immunogold electron microscopic analyses were performed on sections of the gastrocnemius 
muscle of mice. This revealed that in many fibers, MMP-2 was concentrated but not 
exclusively seen in the Z-bands (Figure 1C). In cross sections, MMP-2 could be detected in 
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the periphery of the myofibrils, probably in the sarcoplasmic reticulum or in T-tubuli (Figure 
1D). MMP-2 labeling was also observed in mitochondria (Figure 1E) as well as along the 
nuclear membrane (Figure 1F) and some scattered labeling throughout the muscle in 
unspecified compartments.  Negative control sections did not reveal any labeling 
(Supplementary file Figure S1F).  
To verify presence of MMP-2 in muscle by an antibody independent method, which would 
also detect all other gelatinolytic enzymes in the muscles, tissue extracts of the gastrocnemius 
muscle from untrained mice as well as serum-free conditioned medium and cell lysate of the 
murine myoblast cell line C2C12 were subjected to SDS-PAGE gelatin zymgraphy. The 
zymography gels revealed strong gelatinolytic bands at 72 kDa, corresponding to the mass of 
MMP-2, from all samples (Figure 2a), as well as a bands of about 75 kDa of unknown nature. 
Lanes loaded with C2C12 serum-free, conditioned medium and cell lysate also showed 
gelatinolytic bands corresponding to processed MMP-2 (about 65 and 60 kDa). Some of the 
lanes loaded with muscle extracts revealed a diffuse band of about 110 kDa which may 
correspond to mouse MMP-9, reported to be somewhat larger than human due to more 
extensive glycosylation (Masure et al., 1997). In gels where EDTA was added to the washing 
and incubation buffer, all bands disappeared, confirming that the gelatinolytic bands were 
produced by metalloproteases (Figure 2b). Mass spectrometry confirmed presence of MMP-2 
and also detected MMP-14, MMP-23 and MMP-24 in C2C12 cell lysate (data not shown).  
To investigate presence of inhibitors of gelatinolytic enzymes in muscles, the same samples 
were subjected to real-time reverse gelatin zymography, using MDPF-labeled gelatin in the 
gels. All samples contained inhibitors with mass corresponding to TIMP-1 (28 kDa) in the 
THP-1 medium (leukemic monocyte cell line) used as molecular mass standard (Figure 2c). 
The muscle extracts and myoblast cell lysate produced additional bands with various 
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molecular masses.  Mass spectrometry analyses detected TIMP-1, TIMP-2 as well as TIMP-3 
in the C2C12 cell lysate (data not shown).  
Intracellular MMP-2 was co-localized with gelatinolytic activity 
To investigate if the intracellular MMP-2 was active, in situ gelatin zymography was 
performed followed by immunofluorescent staining for MMP-2. MMP-2 is a potent 
gelatinolytic enzyme, and accordingly, intracellular gelatinolytic activity (Figure 3A) was 
found to be co-localized with MMP-2 staining (Figure 3A-D).  In situ gelatin zymography 
further revealed strong activity  in the periphery  of muscle fibers, accompanied by punctuated 
activity inside the fibers in muscles from both mice (Figure 3A and E) and human 
(Supplementary file Figure S2A). There was a distinct difference in staining intensity between 
adjacent fibers (Figure 3E, S2A). In longitudinally cut muscles (Figure 3A) prominent 
gelatinolytic activity was seen with the same cross-striated pattern as the MMP-2 staining 
(Figure 3B). In contrast to the immunohistochemical MMP-2 staining, no distinct 
gelatinolytic activity was seen in the nuclear membrane, indicating that the enzyme in this 
location was inactive. Addition of the metalloprotease inhibitor EDTA caused an almost 
complete inhibition of the gelatinolytic activity (Figure 3F, supplementary file Figure S2B), 
indicating that metalloproteases were responsible for the observed activity. The selective 
gelatinase inhibitor CTT2 also showed a strong inhibitory effect (Figure 3G), though not as 
complete as EDTA, supporting that MMP-2 was active inside the muscle fibers. The cysteine 
protease inhibitor E-64 had no apparent effect on the activity (Figure 3H). No activity was 
seen in the freeze-inhibited sections (Supplementary file Figure S2C), indicating that there 
was no auto-fluorescence in the tissue.  
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Fast twitch type II fibers had more intracellular gelatinolytic activity than 
slow twitch type I fibers 
In the muscle fibers we could see abundant MMP-2 staining and co-localized gelatinolytic 
activity in normal, healthy muscle fibers, but the intensity of both the staining and the 
gelatinolytic activity varied among individual fibers in the same muscle bundle. To 
investigate if this difference in gelatinolytic activity corresponded to muscle fiber type, we 
performed ATPase staining (pH 4.5 and pH 9.4) on unfixed, snap-frozen muscle tissue (from 
the vastus lateralis and biceps muscles) to separate type I slow twitch and type II fast twitch 
muscle fibers. In situ gelatin zymography was performed on serial sections from the same 
tissue. As snap-freezing does not preserve the morphology of the tissue as well as ZBF, the 
images from these experiments doesn’t reveal as many details as those from analyses of ZBF-
fixed samples as shown in the other figures. At pH 9.4 the type II fibers show strong ATPase 
activity and develop a dark brown color, whereas type I fibers show weak ATPase activity 
and develop a light brown color. At pH 4.5 the picture is opposite (Engel and Tice, 1966). 
Comparison of the same areas in ATPase stained sections at pH 9.4 and in consecutive 
sections subjected to in situ gelatin zymography (Figure 4, upper panel) showed a strong 
correlation between gelatinolytic activity and fiber type. Type II fibers appeared to have 
significantly more gelatinolytic activity than type I fibers. This was also the case with ATPase 
staining at pH 4.5 (Figure 4 lower panel). 
 
Intracellular gelatinolytic activity and MMP-2 expression was reduced by 
physical exercise  
 To investigate whether increased physical exercise  could affect the level of intracellular 
gelatinolytic activity in muscles, in situ gelatin zymography was performed on the 
gastrocnemius muscle from  C57BL/6J mice exposed to high intensity tread mill running for 
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five consecutive days (Figure 5B) and their untrained littermates (Figure  5A).  Quantification 
of mean fluorescence intensity (Figure 5E) representing gelatinolytic activity showed a 
statistically significant decrease (p < 0.001) in fluorescence intensity in both type I and type II 
fibers of mice exposed to high intensity interval training compared to the control littermates. 
To verify that MMP-2 contributed to this difference in gelatinolytic activity, the gelatinase 
inhibitor CTT2 was added to control sections. This showed a strong inhibitory effect in both 
groups (data not shown). Furthermore there was a strong correlation between intensity of 
MMP-2 immunofluorescent staining and level of gelatinolytic activity (Figure 5A, B, D, E, 
F). The differences in MMP-2 staining intensity between trained and normal mice were also 
statistically significant for both type I and type II fibers (P < 0.001).  
Discussion 
In this study we show, by immunohistochemistry and immunogold electron microscopy, that 
MMP-2 is localized intracellularly in compartments other than the secretory pathways in 
skeletal muscle fibers. We found the enzyme concentrated, but not exclusively expressed in 
Z-lines of the sarcomere, in mitochondria as well as in the nuclear membrane of normal 
skeletal muscle fibers, but further studies are warranted to precisely determine the 
intracellular localizations of MMP-2. Immunohistochemical staining of MMP-2 was co-
localized with gelatinolytic activity in the muscle fibers, although there were compartments 
with MMP-2 staining that did not reveal gelatinolytic activity, such as the nuclear membrane. 
This indicates that the MMP-2 in this location was inactive. The gelatinolytic activity was 
almost completely inhibited by the metalloprotease inhibitor EDTA. The  selective  MMP-2 
and MMP-9 inhibitor CTT2 (Heikkila et al., 2006) also had a strong inhibitory effect, 
although not as complete as EDTA. Immunohistochemical staining for MMP-9, the other 
member of the MMP gelatinase group, was negative in the muscle fibers. Also SDS-PAGE 
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zymography of myoblast cell lysates and conditioned medium showed strong bands 
corresponding to masses of both pro-and active MMP-2 but no MMP-9 bands. A diffuse band 
corresponding to the molecular mass of mouse MMP-9 was seen in zymography gels of 
mouse muscle tissue extracts, and may be from stromal cells such as macrophages which are 
known to produce MMP-9 constitutively (Vandooren et al., 2013). Thus, our results strongly 
suggest that MMP-2 was the main active gelatinase within the muscle fibers.  
 
Real-time reverse gelatin zymography revealed that there were inhibitors of gelatinolytic 
enzymes present in both muscle tissue extracts, muscle cell lysates and in conditioned 
medium from the muscle cells with masses corresponding to TIMP-1 in the standard. The 
tissue extracts and cell lysates contained additional inhibitors with various molecular masses. 
By mass spectrometric analyses TIMP-1, TIMP-2 and TIMP-3 were identified in some of 
these bands. These results indicate that there are several more MMP-inhibitors present 
intracellularly or at the cell membrane than in the conditioned medium.    
 
MMP-2 is synthesized with an N-terminal signal sequence that directs the protein for 
secretion, and it is usually activated by MMP-14 at the cell membrane (Hadler-Olsen et al., 
2011a). Lately however, several mechanisms for intracellular recruitment and activation of 
the enzyme have been revealed. An alternative splice variant of MMP-2 lacking the signal 
sequence was recently discovered, which may account for some of the intracellular pool of the 
enzyme (Ali et al., 2012). In addition, the signal sequence of MMP-2 was found to be weak, 
causing retention of a substantial amount of the signal sequence containing MMP-2 within the 
cells. These mechanisms of intracellular localization of MMP-2 were demonstrated in various 
cell types, among them cardiomyocytes (Ali et al., 2012), and may cause intracellular 
retention of MMP-2 also within skeletal muscle fibers. Another recent publication reported an 
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alternative MMP-2 splice variant lacking both the N-terminal signal sequence as well as the 
inhibitory pro-domain.  This truncated and active form of the enzyme was found in the 
cytosolic and mitochondrial fraction of cardiomyocytes and was induced in response to 
oxidative stress   (Lovett et al., 2012). Upon oxidative stress, full-length MMP-2 has also been 
found to be activated by peroxynitrite and glutathione through  modification of the cysteine 
residue of the enzymes inhibitory pro-domain in cardiomyocytes (Viappiani et al., 2009). As 
reactive oxygen and nitrogen species are produced in skeletal muscle during contraction 
(Balon and Nadler, 1994; Pattwell et al., 2004; Powers et al., 2011), the intracellular MMP-2 
activity may be due to the same mode of enzyme activation. There are also studies showing 
that binding of MMPs to  molecules such as SIBLING proteins and the alpha 2 chain of 
collagen type VI can induce conformational changes that dislocates the pro-domain from the 
active site giving an active, full-length enzyme (Fedarko et al., 2004; Freise et al., 2009). This 
suggests that MMP-2 could also be activated by binding to intracellular proteins in the 
skeletal muscle cells without being proteolytically processed. By mass spectrometry, we 
detected TIMP-2, MMP-14 and MMP-24 in the myocytes. TIMP-2 and MMP-14 are known 
activators of MMP-2 (Hadler-Olsen et al., 2011a), and MMP-24 is also believed to be a potent 
MMP-2 activator (Llano et al., 1999), showing that the myocytes also produce the proteins 
needed for proteolytic activation of MMP-2.  
 
Along with discoveries of intracellular recruitment and activation mechanisms of MMP-2, a 
number of putative intracellular substrates have been identified. By processing α-actinin-1, 
desmin, myosin light chain-1, troponin I or titin in cardiomyocytes MMP-2 may contribute in 
regulation of contractile force (Sung et al., 2007a; Cauwe and Opdenakker, 2010; Ali et al., 
2011). In vitro studies have also demonstrated that MMP-2 is able to process several 
mitochondrial proteins such as heat shock protein 75, -90α and -90β and peroxiredoxin 5, 
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linking the enzyme to regulation of protein folding and antioxidant activity (Cauwe and 
Opdenakker, 2010). Within a muscle bundle, we found that the gelatinolytic activity was 
much stronger in fast twitch type II fibers than in slow twitch type I fibers as judged by 
ATPase staining and gelatin in situ zymography of the same tissue. In accordance with our 
findings, it has previously been reported that muscles with abundance of type II fibers, 
express more MMP-2 at both mRNA and protein level than muscles containing mainly type I 
fibers (Carmeli et al., 2005; Carmeli et al., 2010). These previous studies have looked at 
protein expression in muscle homogenates where the extracellular matrix and blood from the 
microcirculation might have contributed to the pool of MMP-2. Therefore, the sources of 
MMP-2, and the precise localization of the enzyme in the muscles cannot be determined from 
these previous studies.  Fast twitch type II fibers have high levels of glycolytic enzymes 
(Schiaffino and Reggiani, 2011), and a number of these, such as enolase-α, -β and γ, fructose-
bisphosphate, aldolase A and GAPDH, are identified as putative intracellular MMP-2 
substrates (Cauwe and Opdenakker, 2010).  Proteolytic processing of these enzymes by 
MMP-2, could explain why we detected more gelatinolytic activity in the glycolytic type II 
fibers than in oxidative type I fibers, and suggest a role of MMP-2 in regulation of 
carbohydrate metabolism.  
 
We found a statistically significant decrease in intracellular gelatinolytic activity in muscles 
from mice exposed to high intensity interval training. In contrast to our results, increased 
levels of MMP-2 in muscles have previously been reported after 10 days of endurance 
exercise in humans, and after two to eight weeks of high-intensity training in rats (Carmeli et 
al., 2005; Rullman et al., 2009; Carmeli et al., 2010; Deus et al., 2012) . Furthermore, a study 
by Yeghiazaryan et al. found gelatinolytic activity in the nucleus of skeletal muscles in rats 
which increased after 5 days of repeated physical training (Yeghiazaryan et al., 2012). The 
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discrepancy between these studies and ours may be due to species differences, as we have 
studied mouse muscle, and not rat. The relative intensity and duration of the exercise 
regiments may also contribute to different results, as well as differences in experimental 
conditions and detection methods. Except the study by Yeghiazaryan et al., these previous 
studies have not discriminated between intracellular and extracellular MMP-2 in the muscles, 
so the apparent discrepancy between our results and previous results may be due to increased 
MMP-2 secretion along with less intracellular retention during high- intensity training. This is 
in line with studies from cardiomyocytes, where ischemia-reperfusion injuries caused 
increased MMP-2 levels in the coronary effluents which were accompanied by a depletion of 
intracellular MMP-2 levels (Cheung et al., 2000). Ischemia-reperfusion injuries in hearts have 
furthermore been shown to cause a rapid induction of MMP-2 transcription, which may 
quickly re-establish intracellular MMP-2 levels (Alfonso-Jaume et al., 2006). The reduced 
levels of MMP-2 and gelatinolytic activity that we measured in muscles from trained mice 
could therefore be due to the fact that they were sacrificed only minutes after the last round of 
exercise, before the MMP-2 levels had been reestablished.  If contraction induces activation 
of intracellular MMP-2, this could be a control mechanism to avoid harmful over-activity of 
the enzyme inside the muscle cell, or due to increased need of extracellular MMP-2 upon 
muscle contraction.   
 
Taken together our results demonstrate intracellular localization and activity of MMP-2 in 
skeletal muscle fibers, which is most prominent in type II fast twitch fibers. The amount and 
activity of the enzyme was affected by physical activity. The specific intracellular functions 
of the enzyme can so far only be speculated. MMPs have long been regarded as appealing 
drug targets in various diseases, especially in cancer patients, where broad spectrum MMP-
inhibitors have been tested in clinical trials. Musculoskeletal pain has been a frequent side 
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effect reported after prolonged use of such inhibitors (Zucker et al., 2000; Brinckerhoff and 
Matrisian, 2002; Coussens et al., 2002), and suggests that MMPs are implicated in muscular 
physiology.  Thus to be able to develop safe and predictably working MMP-inhibitors, and to 
expand our understanding of the physiology of skeletal muscles, further studies of these new 
aspects of MMP-2 biology  are warranted.   
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Figure 1: Intracellular MMP-2 localization 
Representative images from at least four independent experiments of immunohistochemical 
MMP-2 staining of longitudinally (A) and transversely (B) cut muscle fibers in mouse tongue. 
MMP-2 staining is seen as brown color, whereas nuclei are stained blue by hematoxylin. In C-
F representative images of immunogold electron microscopic MMP-2 staining of mouse 
gastrocnemius muscle is shown, MMP-2 staining is seen as dark spots. Figure 1C 
demonstrates concentration of the enzyme in Z-bands (Z) in cross section, in (D) labeling is 
seen surrounding myofibrils, image (E) shows concentration of labeling in mitochondria (M) 
and image (F) at the nuclear membrane.  
 
Figure 2 
(A) Representative images of at least three independent experiments of SDS-PAGE gelatin 
zymography gels of muscle cell extracts (ME) left panel, serum-free, conditioned medium 
(M) of the myoblast cell line C2C12 in the middle panel,  and cell lysates of the C2C12 cell 
line in the right panel. Molecular weight standard (St) contains pro- and processed MMP-9 
(92 and 82 kDa respectively) and pro- and processed MMP-2 (72 and 62 kDa respectively). 
Gelatinolytic enzymes are seen as clear bands on the gel. (B) To assess contribution of 
metalloproteases to the gelatinolytic activity, parallel gels were run without (left panel) and 
with (right panel) 10 mM EDTA in the washing and incubation buffer. (C)The same samples 
were also subjected to real-time reverse gelatin zymography in a polyacrylamide gel with co-
polymerized gelatin and MMP-9, to analyze presence of inhibitors of gelatinolytic enzymes. 
Inhibitors are seen as light bands against a darker background. MMP-2 and MMP-9 are seen 
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as distinct dark bands at 92 and 72 kDa. Standard (St) contains TIMP-1 in addition to MMP-9 
and MMP-2 as described above. 
 
Figure 3: Gelatinolytic activity and co-localized MMP-2 staining 
Representative images of longitudinally cut muscle fibers from mouse tongue subjected to 
gelatin in situ zymography without inhibitors (A), immunofluorescent staining for MMP-2 
(B), nuclear staining with DAPI (C) and overlay of A-C (D). Gelatinolytic activity is seen as 
green fluorescence, MMP-2 is seen as red fluorescence, nuclei are stained blue by DAPI and 
co-localization of gelatinolytic activity and MMP-2 staining is seen as yellow color on the 
overlay picture (D). Representative images of in situ gelatin zymography from at least three 
independent experiments of muscle fibers from gastrocnemius muscle of mouse in cross 
section without any inhibitors (E), with 20 mM EDTA (F), with 100 µM CTT2 (G) and 
with10 µg/ml E-64 (H). Gelatinolytic activity is seen as green fluorescence, whereas nuclei 
are labeled blue by DAPI.   
 
Figure 4: ATPase staining and gelatinolytic activity 
In the upper panel a representative image of ATPase staining at pH 9.4 in a section from the 
vastus lateralis muscle from human is shown, as well as gelatinolytic activity, demonstrated 
by in situ gelatin zymography, from a sequential section of the same muscle sample.  At pH 
9.4 ATPase activity is seen as dark brown staining in fast twitch type II muscle fibers, 
whereas slow twitch type I fibers have a light brown color. In the lower panel a representative 
image of ATPase staining at pH 4.5 in a section from the vastus lateralis muscle from another 
human is shown, as well as gelatinolytic activity, demonstrated by in situ gelatin zymography, 
from a sequential section of the same muscle sample.  At pH 4.5 ATPase activity is seen as 
light brown staining in fast twitch type II muscle fibers, whereas slow twitch type I fibers 
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have a dark brown color. In both upper and lower panel, gelatinolytic activity is seen as green 
fluorescence, whereas nuclei are stained blue by DAPI. Corresponding fast twitch type II 
fibers are labeled with the same numbers in pictures of ATPase staining and gelatinolytic 
activity in both panels.  
 
Figure 5: Gelatinolytic activity and MMP-2 staining in gastrocnemius muscle from normal, 
and trained mice 
Representative images of gelatinolytic activity (A, B) and MMP-2 staining (C, D) in 
gastrocnemius muscle from normal control mice (A, C), and mice exposed to five days of 
high intensity interval training (B, D). Gelatinolytic activity is seen as green fluorescence and 
MMP-2 is seen as red fluorescence. Histogram showing quantification of differences in 
fluorescence intensity, representing gelatinolytic activity from in situ zymography (E), or 
MMP-2 staining (F) between normal, trained and db/db mice. Fiber type I and II are analyzed 
separately and the results are presented by means. Error bars indicate 95% CI, and * indicate 
p < 0.001.   
 
Supplementary file 
Materials and methods 
Mass spectrometry 
To identify unknown gelatinolytic inhibitors detected by reverse SDS-PAGE substrate 
zymography, muscle tissue extract, C2C12 serum-free conditioned medium and cell 
lysate were subjected to non-reducing SDS-PAGE (NuPAGE Novex 4-12% Bis-Tris gels, 
Invitrogen, Carlsbad, CA). The gel was stained with Imperial Protein Stain (Thermo 
Scientific, Rockford, IL), and all defined protein bands with masses between 30 and 10 
kDa were cut out. Additionally, bands with masses between 80-60 kDa were cut out. Gel 
pieces were subjected to in gel reduction, alkylation, and tryptic digestion using 6 ng/μl 
trypsin (V511A, Promega, Wisconsin, USA)(Shevchenko et al., 1996). OMIX C18 tips 
(Varian, Inc., Palo Alto, CA, USA) was used for sample clean-up and concentration. 
Peptide mixtures containing 0.1% formic acid were loaded onto a Thermo Fisher 
Scientific EASY-nLC1000 system and EASY-Spray column (C18, 2µm, 100 Å, 50µm, 15 
cm). Peptides were fractionated using a 2-100% acetonitrile gradient in 0.1 % formic 
acid over 50 min at a flow rate of 250 nl/min. The separated peptides were analyzed 
using a Thermo Scientific Q-Exactive mass spectrometer. Data was collected in data 
dependent mode using a Top10 method. The raw data was processed using the 
Proteome Discoverer 1.4 software. The fragmentation spectra were searched against the 
Swissprot SwissProt_2011_12 database using an in-house Mascot server (Matrix 
Sciences, UK). Peptide mass tolerances used in the search were 10 ppm, and fragment 
mass tolerance was 0.02 Da. Peptide ions were filtered using a false discovery rate (FDR) 
set to 2 % for peptide identifications. 
 
Supplementary Figure captions 
Figure S1: 
Representative images of immunohistochemimal staining for MMP-2 in human tongue 
muscle cut longitudinally (A) and cross sectioned (B). MMP-2 staining is seen as brown 
color whereas nuclei are stained blue by hematoxylin. Representative image of negative 
control section for immunohistochemical MMP-2 staining where the primary MMP-2 
antibody was replaced by 1.5 % normal goat serum is shown in C. Representative 
images of immunohistochemical staining for MMP-9 in tongue muscles from mouse (D) 
and human (E). MMP-9 staining is seen as brown color, whereas nuclei are stained blue 
by hematoxylin. Representative image of negative control of MMP-2 immunogold 
labeling of mouse gastrocnemius muscle where the primary antibody was omitted is 
shown in F.   
 
Figure S2 
Representative images of in situ gelatin zymography of muscle fibers from human 
tongue without any inhibitors (A) and with 20 mM EDTA (B). A control section 
incubated at -20 ̊ C is shown in C. Gelatinolytic activity is seen as green fluorescence, 
whereas nuclei are labeled blue by DAPI.   
 
 
 







